Morgan Stanley Smith Barney files Rule 144 notice for common shares

Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting proposed sales of Common Stock.

Accepted by SEC EDGAR 05/18/2026 - 04:21 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting proposed sales of Common Stock. The filing lists 01/03/2025 restricted shares of 6,185 and 01/06/2026 restricted shares of 60,975. The entries identify the securities as Restricted Stock and the transaction venue as NASDAQ.

Insights

Securities Counsel

Rule 144 notice documenting proposed resale of restricted common shares.

The filing lists two restricted stock lots: 01/03/2025 for 6,185 shares and 01/06/2026 for 60,975 shares. It identifies the seller entity as Morgan Stanley Smith Barney LLC in an execution/filing role.

These entries function as a compliance notice under Rule 144 rather than an executed public sale; timing and cash‑flow outcomes depend on subsequent sales and any vesting or transfer conditions.

Key Figures

Restricted lot 1: 6,185 shares Restricted lot 2: 60,975 shares Exchange indicated: NASDAQ

3 metrics

Restricted lot 1 6,185 shares Restricted Stock dated 01/03/2025

Restricted lot 2 60,975 shares Restricted Stock dated 01/06/2026

Exchange indicated NASDAQ Trading venue listed on the filing

Key Terms

Restricted Stock, Form 144, Issuer

3 terms

Restricted Stock financial

"Common | 01/03/2025 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Issuer regulatory

"Restricted Stock | Issuer | | | 6185"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CLOV Form 144 filing report?

It reports proposed resale of restricted common stock totaling two lots: 6,185 and 60,975 shares. The filing lists these as Restricted Stock with dates 01/03/2025 and 01/06/2026, and indicates NASDAQ as the exchange.

Who is listed as the filer on the Form 144 for CLOV?

The filer is listed as Morgan Stanley Smith Barney LLC. The filing entry shows this entity and provides an address for its Executive Financial Services unit in New York, indicating the broker/dealer role in the proposed resale notification.

Are the Form 144 shares already sold for CLOV?

No sale execution is stated; Form 144 is a notice of proposed sale. The filing lists the restricted share lots and dates but does not document completed public sales or cash proceeds from those shares in the provided excerpt.

Does the filing disclose proceeds or prices for the CLOV shares?

The excerpt does not state sale prices or proceeds. It lists share counts and restricted stock dates but contains no dollar amounts tied to consummated transactions, so pricing and cash‑flow details are not included here.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001937412
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CLOVER HEALTH INVESTMENTS, CORP.
SEC File Number	001-39252
Address of Issuer	1209 Orange Street Wilmington DELAWARE 19801
Phone	(201) 432-2133
Name of Person for Whose Account the Securities are To Be Sold	CARLADENISE A EDWARDS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	67160	229129.77	430969398	05/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/03/2025	Restricted Stock	Issuer			6185	01/03/2025	Not Applicable
Common	01/06/2026	Restricted Stock	Issuer			60975	01/06/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	05/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Carladenise Armbrister Edwards
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)